
Content on PharmTech.com this week ranged from fundamentals on the use of digital pathology in drug development, discussions on the use of AI in pharma, and regulatory actions impacting the industry.
Eurofins MWG Operon expands its exome sequencing services with the Ion Proton Next Generation Sequencer.
Source:






